FDA granted regular approval to dabrafenib and trametinib in combination for the adjuvant treatment of patients with BRAF V600E or V600K melanoma

 

1 reply

Trackbacks & Pingbacks

  1. […] post FDA granted regular approval to dabrafenib and trametinib in combination for the adjuvant treatment … appeared first on Medical Writer Agency | 香港醫學作家 | MediPR | MediPaper Hong […]

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply